Hydrolytic enzyme inhibitors/inactivators and methods for using same
AssigneeThe Regents of the University of California
InventorsEdward A. Dennis, William N. Washburn
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds that function as hydrolytic enzyme inhibitors (inactivators) and substrates. These compounds are useful in assays to detect and measure levels of hydrolytic enzyme activity and are more particularly useful in treatment regimens for various disease states and conditions implicating the underlying specific hydrolytic enzyme. Examples of hydrolytic enzymes include, but are not limited to, phospholipases, lipases, esterases, proteases, etc.
Claims9
A method of inactivating or inhibiting a phospholipase A enzyme, comprising administering to a subject susceptible to or experiencing a condition mediated by the activity of said enzyme an amount sufficient to inactivate or inhibit the activity of said enzyme of a pharmaceutically acceptable form of a compound of the formula:
- ##STR6## wherein R is oxygen or imino,
- each X independently is oxygen, sulfur or imino,
- A is a moiety recognized by phospholipase A enzyme such that said enzyme hydrolyses the bond linking AX with C(O)Y,
- B is a physiologically acceptable leaving group,
- Y is an alkylene or alkenylene or alkylene or alkenylene substituted with one or more lower alkyl groups.
Dependencies are inferred from the claim text.